Overview: Lenvima 10 mg (Lenvatinib)
Lenvima 10 mg, containing the active ingredient Lenvatinib mesylate (12.25 mg equivalent to 10 mg Lenvatinib), is a specialized oncology medication developed by Eisai. It is classified as a kinase inhibitor, engineered to interfere with specific signaling pathways to manage malignancies.
Composition and Specifications
- Active Ingredient: Lenvatinib mesylate (12.25 mg).
- Capsule Shell Colors: Titanium dioxide, Yellow iron oxide, Red iron oxide, and Black iron oxide.
Product Details and Usage
Lenvima 10 mg is provided in a pack containing 2 strips of 10 capsules each (2 x 10 Capsules).
Safety and Storage Guidelines
Dosage: As directed by the physician. This product must be sold by retail on the prescription of an oncologist only.
Storage: Store below 30°C. Keep out of reach of children.
Healthcare Collaboration: For complete information, see the package insert. Maintain consistent communication with your oncology care team and the specialists at El-Masry Pharmacy to ensure optimal treatment outcomes.
Disclaimer: Lenvima is a specialized, prescription-only oncology medication. Ensure you hold a valid prescription from an oncologist and consult with your healthcare provider before beginning any treatment plan.
You can add a rating once you purchase the product through the My Orders page
